Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Revenue

In the year 2025, Hyloris Pharmaceuticals had annual revenue of 8.83M EUR, down -9.50%. Hyloris Pharmaceuticals had revenue of 5.49M in the half year ending December 31, 2025, with 197.62% growth.

• Revenue: 8.83M
• Revenue Growth: -9.50%
• P/S Ratio: 15.22
• Revenue / Employee: 176.66K
• Employees: 50
• Market Cap: 134.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.83M	-927.00K	-9.50%
Dec 31, 2024	9.76M	6.00M	159.64%
Dec 31, 2023	3.76M	1.37M	57.48%
Dec 31, 2022	2.39M	-709.00K	-22.90%
Dec 31, 2021	3.10M	2.92M	1,669.14%